Status:
UNKNOWN
Nordic Cystectomy Study II - Albumin
Lead Sponsor:
Turku University Hospital
Collaborating Sponsors:
Nordic Urothelial Cancer Group
Conditions:
Bladder Cancer
Invasive Bladder Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Around 7200 cases of Muscle Invasive Bladder Cancer are diagnosed annually in the Nordic countries combined. Muscle Invasive Bladder Cancer is an aggressive disease and it is linked with high mortalit...
Eligibility Criteria
Inclusion
- Histologically confirmed urinary BC planned to be treated with RC with or without neoadjuvant chemotherapy.
- Histologically confirmed urinary BC planned to be treated with palliative cystectomy
- 2\) Signed informed consent 3) Patient age \>18 years
Exclusion
- RC for other reasons than BC
- Other forms of surgical treatment of BC than RC (e.g. bladder resection).
- Patient unwillingness to participate in the study for any reason (i.e. lack of signed consent).
Key Trial Info
Start Date :
August 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2025
Estimated Enrollment :
1700 Patients enrolled
Trial Details
Trial ID
NCT04523038
Start Date
August 30 2020
End Date
August 30 2025
Last Update
November 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Turku, Hospital Distric of Southwest Finland
Turku, Southwest Finland, Finland, 20521